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Abstract 
Background: C1q has been reported to reveal complement‑independent roles in immune and non‑immune cells. 
C1q binds to its specific receptors to regulate distinct functions that rely on the environment and cell types. Discoidin 
domain receptor 2 (DDR2) is activated by collagen and functions in wound healing by controlling matrix metallopro‑
teinase (MMP) expression. Since C1q exhibits a collagen‑like structure, we hypothesized that C1q might engage DDR2 
to regulate wound healing and extracellular matrix (ECM) remodeling.
Methods: Cell‑based assay, proximity ligation assay, ELISA, and surface plasmon analysis were utilized to investigate 
DDR2 and C1q binding. We also investigate the C1q‑mediated in vitro wound healing ability using the human fibro‑
sarcoma cell line, HT1080.
Results: C1q induced the phosphorylation of DDR2, p38 kinase, and ERK1/2. C1q and DDR2 binding improved cell 
migration and induced MMP2 and MMP9 expression. DDR2‑specific shRNA reduced C1q‑mediated cell migration for 
wound healing.
Conclusions: C1q is a new DDR2 ligand that promotes wound healing. These findings have therapeutic implications 
in wound healing‑related diseases.
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Background
Wound healing remains a clinical challenge, and efficient 
wound management is important for preventing chronic 
wounds. Wound healing integrates various resident and 
migratory cells, the extracellular matrix, growth fac-
tors, and cytokines involved in the inflammation, prolif-
eration, and remodeling phases (Velnar et al. 2009). This 
complex process involving migration, proliferation, inter-
action, and differentiation of epidermal or dermal cells, 
biomolecular interactions, synthesis of matrix compo-
nents occur in the injured tissue to restore wound heal-
ing (Masson-Meyers et al. 2020; Thomas 2011). Epithelial 
cells play a crucial role during the wound healing process 
by proliferating and migrating toward the injured area 
(Leoni et al. 2015; Landen et al. 2016). Chronic diseases 
such as obesity or diabetes delay wound healing, and 
the studies of wound assessment strategies will benefit 
wounded patients (Masson-Meyers et al. 2020).
C1q is the first complement component. It serves as 
a recognition signal that triggers the classical pathway 
and induces the clearance of apoptotic cells and immune 
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complexes (Thielens et  al. 2017; Trinder et  al. 1996; 
Nayak et al. 2010). C1q consists of six trimeric globular 
heads (gC1q) and a collagen-like tail with Gly-Pro-Hyp 
collagen-like sequence repeats (cC1q) (Reid 1974). C1q 
in human serum binds with danger-associated molecular 
patterns (DAMPs) released from apoptotic and necrotic 
cells, including phosphatidylserine, nucleic acids, and 
HMGB1 (Lee et  al. 2018; Son et  al. 2016; Kim et  al. 
2018). In response to infection, C1q also binds to path-
ogen-associated molecular patterns (PAMPs), includ-
ing lipopolysaccharides. With these features, C1q is 
anchored to the membrane and functions in phagocyto-
sis, angiogenesis, apoptosis, and cytokine or chemokine 
induction, which are important for modulating the 
inflammatory response (Kishore et  al. 2004; Ghebrehi-
wet et  al. 2017). Privileged engagement of distinct C1q 
(gC1q vs. cC1q) regions occurs during different stages 
of immune cell activation and function (Thielens et  al. 
2017; Nayak et al. 2010). The diversity of C1q functions is 
related in part to its domain and depends on each recep-
tor. There are several C1q receptors on the cell surface: 
(1) gC1q receptors, including the receptor for advanced 
glycation end products (RAGE), Siglec-3, CD91, CD33, 
and dendritic cell-specific intercellular adhesion mol-
ecule-3 grabbing non-integrin (DC-SIGN); and (2) cC1q 
receptors, including calreticulin and leukocyte-associ-
ated immunoglobulin-like receptor 1 (LAIR-1) (Thielens 
et  al. 2017; Son et  al. 2015; Son et  al. 2012; Son et  al. 
2017). cC1q exhibits structural similarities with collagen 
VIII and X and the collagen receptors α2β1, LAIR-1, and 
DDR1 have been reported to be C1q receptors (Lee et al. 
2018; Son et al. 2015).
Although several studies have elucidated the role of C1q 
in non-hematopoietic cells, the physiological receptor for 
C1q in non-hematopoietic cells and the mechanism of 
C1q in the wound healing process remain unclear. C1q 
is expressed by invading trophoblast and endothelial cells 
and contributes to vascular and tissue remodeling (Ago-
stinis et al. 2016). C1q is highly expressed in the stroma 
and vascular endothelium in tumor microenvironments; 
therefore, it can serve as a cancer-promoting factor (Bulla 
et  al. 2016). C1q also enhances endothelial cell prolif-
eration and migration, tube formation, and angiogenesis 
(Ghebrehiwet and Peerschke 2004; Bossi et al. 2014; Feng 
et al. 2002).
Discoidin domain receptors (DDRs), including DDR1 
and DDR2, are classified as receptor tyrosine kinases 
(RTKs) based on the presence of a catalytic kinase 
domain (Shrivastava et al. 1997). DDRs are activated by 
fibrillar and non-fibrillar collagens, which are the major 
components of all types of extracellular matrix (ECM), 
thus playing a role in the regulation of collagen–cell 
interactions (Marquez and Olaso 2014; Vogel et al. 1997). 
ECM remodeling is associated with matrix metallopro-
teinase (MMP) production, which is important in re-epi-
thelialization (Marquez and Olaso 2014) as it allows for 
cell migration and tissue remodeling (Caley et al. 2015). 
Abnormalities in the healing process and dysregulation 
of MMPs lead to prolonged inflammation and chronic 
wounds. DDR2 is activated by fibrillar collagen, spe-
cifically collagen type I (Vogel et al. 1997). The catalytic 
tyrosine kinase domain of DDR2 undergoes phospho-
rylation following fibrillar collagen binding (Vogel et  al. 
1997). Unlike other RTKs, DDR2 phosphorylation occurs 
long after ligand binding and is sustained for over 24  h 
(Iwai et al. 2013). DDR2 is well-known for its function in 
wound healing.  DDR2−/− mice showed delayed closure of 
dermal wounds (Olaso et al. 2011). Furthermore, DDR2 
is required for proliferative response during skin wound 
healing (Labrador et al. 2001).
Fibroblasts in human acute wounds express MMP2 
and endothelial cells to accelerate cell migration (Gian-
nelli et al. 1997). Likewise, MMP9 is expressed in several 
injured epithelia to promote wound healing (Mohan et al. 
2002). Types I, II, III, IV, and V collagens activate DDR1, 
while types I, II, III, and X collagens stimulate DDR2 
(Shrivastava et  al. 1997; Leitinger 2011). Human DDR1 
and DDR2 exhibit about 50% sequence homology and 
have a discoidin-homology domain (DD), a discoidin-like 
domain (DLD), an extracellular juxtamembrane domain, 
a transmembrane domain, a cytosolic domain, and a 
tyrosine kinase domain. Collagen binding to the DD 
induces receptor autophosphorylation (Leitinger 2003).
DDR2 signaling is required for normal bone devel-
opment and wound healing, while DDR1 signaling is 
required for normal skeletal development, mammary 
gland branching morphogenesis, and blastocyst implan-
tation (Marquez and Olaso 2014; Olaso et al. 2011; Borza 
and Pozzi 2014; Page-McCaw et al. 2007; Yan et al. 2014). 
DDR2 is also upregulated in dermal burn wounds (Fee-
zor et  al. 2004). Moreover, DDR2-deficient mice exhibit 
impaired dermal wound healing due to reduced fibro-
blast proliferation and reduced bone growth as a result 
of reduced chondrocyte proliferation (Olaso et al. 2011; 
Olaso et al. 2002).
Considering that C1q and DDRs play roles in wound 
healing and C1q exhibits a collagen-like structure, we 
hypothesized that C1q might engage with DDR2 to 
regulate wound healing. Here, we examined the direct 
binding of DDR2 and C1q and, for the first time, dem-
onstrated the C1q-mediated DDR2 autophosphorylation 
and in vitro C1q-mediated wound healing ability of epi-
thelial cells. The results would help in understanding how 
C1q affects the epithelial cells, and the engagement of 
DDR2 may contribute to the development of successful 
treatments to enhance wound healing.
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Methods
Cell line and culture
The human fibrosarcoma cell line, HT1080 (ATCC CCL-
121; ATCC, Manassas, VA, USA), which is epithelial-like 
and originated from connective tissue and preferentially 
expresses DDR2 mRNA and protein over DDR1 (Saby 
et  al. 2016), was used. HT1080 cells were maintained 
in Minimum Essential Medium (Wellgene, Korea and 
Thermo Fisher Scientific, MA, USA) containing 10% fetal 
bovine serum and 1% penicillin–streptomycin (Wellgene 
and Thermo Fisher Scientific). Cell cultures were main-
tained at 37 °C in the humidified atmosphere of a 5%  CO2 
incubator.
Analysis of C1q binding to DDR2 using enzyme‑linked 
immunosorbent assay (ELISA)
Recombinant human DDR2 possessing the ectodomain 
of DDR2 (Gln24-Arg399) with 6 × His-tag on C-terminal 
(sDDR) was purchased (2538-DR; R&D Systems, Minne-
apolis, MN, USA). For the assay, 2 and 8  μg/mL of col-
lagen-I (C7774; Sigma-Aldrich, Darmstadt, Germany), 
2  μg/mL human C1q protein (C1740; Sigma-Aldrich), 
and sDDR2 were coated on ELISA plates (Corning, NY, 
USA) and incubated at 4  °C overnight. Bovine serum 
albumin (BSA; Sigma-Aldrich) was also coated as a nega-
tive control protein. The plates were washed twice with 
Dulbecco’s phosphate-buffered saline (DPBS; Wellgene) 
and blocked with 200 μL of 3% BSA at 25 °C for 1 h. Vari-
ous concentrations (0.1, 0.5, 2, and 8  μg/mL) of sDDR2 
or C1q were added to the wells and incubated at 37  °C 
for 2  h. After washing, mouse anti-DDR2 (MAB2538; 
R&D Systems) or rabbit anti-C1q antibody (Ab) (A0136; 
Dako Denmark A/S, Glostrup, Denmark) was added in 
3% BSA at RT for 1  h. Horseradish peroxidase (HRP)-
conjugated goat anti-mouse Ab (31430; Life Technolo-
gies, Inc., Gaithersburg, MD, USA) or goat anti-rabbit 
Ab (31460; Life Technologies) was used as the secondary 
Ab. 3,3′,5,5′-Tetramethylbenzidine (TMB) solution was 
added for color development, and the optical density of 
each well was measured at 450  nm. Non-coated blank 
well values were subtracted, and normalized values were 
subjected to statistical analysis.
Analysis of C1qA peptide binding to DDR2 using ELISA
C1qA peptide (Biotin-GSKGEQGEPGAPGI, Gen-
Script, Piscataway, NJ, USA), control peptide (Biotin-
KAEQAEPAAPAI, GenScript), sDDR (2538-DR; R&D 
Systems), or BSA (Roche, Basel, Switzerland) were coated 
on an ELISA plate (Corning) at 8 μg/mL in PBS and incu-
bated overnight at 4  °C. The plates were washed with 
0.05% PBS with Tween-20 (PBST) twice and blocked 
with 1% BSA fraction V (Roche) in PBS at 25 °C for 1 h. 
Various concentrations of sDDR2 (0.1, 0.5, 2, or 8 μg/mL) 
or C1qA peptide (0.1, 0.5, 2, or 8 μg/mL) were added and 
incubated at RT for 2 h. After washing with 0.05% PBST, 
alkaline phosphatase (AP)-conjugated anti-6x-His Ab 
(3D5, Invitrogen, Waltham, MA, USA) for sDDR2 detec-
tion or AP-conjugated streptavidin (7105–04, South-
ern Biotech, Birmingham, AL, USA) for C1qA peptide 
or control peptide were incubated at RT for 1  h. Phos-
phatase substrate (S0942, Sigma-Aldrich) solution was 
added for color development, and the optical density of 
each well was measured at 405 nm.
Surface plasmon resonance (SPR) analysis
SPR (Biacore 3000, GE Healthcare, Chicago, IL, USA) 
analysis was used to detect the interaction of sDDR2 
with C1q proteins. With the scouted buffer conditions 
(10  mM sodium acetate, pH 4.0–6.0), sDDR2 protein 
was immobilized on the surface of the sensor chip CM5 
(GE Healthcare). To derive the ligand values, a coupling 
process was performed based on the molecular weights 
of sDDR2 (MWligand) and C1q (MWanalyte). Samples 
were injected into running buffer consisting of 10  mM 
HEPES (pH 7.4) at 25  °C (10 μL/min flow rate). Sensor-
grams were recorded and analyzed in real time using 
the Biacore 3000 control software. Six concentrations 
of C1q proteins (0, 2.5, 5, 10, 20, and 40  μg/mL) were 
used for binding to derive the  KD values. All exercise 
data were calculated using BIAevaluation Software (GE 
Healthcare).
Pull‑down assay
sDDR2 and C1q proteins were incubated at 37 °C for 2 h. 
Complete His-Tag Purification Resin (5893682001; Roche 
Diagnostics GmbH, Mannheim, Germany) was blocked 
with 3% BSA (Sigma-Aldrich) at 4  °C for 1 h. The resin 
was mixed with the proteins and rotated on a shaker at 
4 °C overnight. After washing with 0.1% PBST, pull-down 
samples were subjected to sodium dodecyl sulphate–pol-
yacrylamide gel electrophoresis (SDS-PAGE) and western 
blot to detect the proteins using mouse anti-DDR2 (R&D 
Systems) and rabbit anti-C1q Ab (Dako). For C1qA pep-
tide and DDR2 binding assay, biotinylated-C1qA peptide 
(20  μg/mL) was precoated on streptavidin-conjugated 
microbeads (SpeedBeads™, Thermo Fisher Scientific). 
Beads were incubated with sDDR2 (1 or 5  μg) at 4  °C 
for 2  h. After extensive washing, DDR2 and C1qA pep-
tide were visualized using western blot and dot blot with 
antibodies for His tag (for DDR2) or infrared 800-labeled 
streptavidin (for biotinylated C1qA peptide). The signals 
were detected by the Sapphire™ Biomolecular Imager 
(Azure Biosystems, Dublin, CA, USA).
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Flow cytometry
HT1080 cells were seeded in 6-well plates at a density of 
5 ×  105 cells/mL, harvested and washed twice with DPBS, 
and then centrifuged at 6000 rpm for 10 min. Next, the 
cells were fixed with 4% paraformaldehyde at RT for 
30 min and washed with DPBS twice. The fixed cells were 
stained with or without rabbit anti-DDR2 Ab (sc-8989; 
Santa Cruz Biotechnology, Dallas, TX, USA) and goat 
anti-rabbit Ab conjugated with Alexa Fluor 488 (A11008, 
Invitrogen, OR, USA) at 4 °C in the dark for 1 h. Human 
IgG Fc at the same concentration was used as the control. 
Cells were washed with DPBS and all stained cell samples 
were analyzed via flow cytometry using the FACSVerse 
system (BD Biosciences, San Jose, CA, USA).
Confocal microscopy
HT1080 cells were seeded in 4-well chamber slides at a 
density of 1.5 ×  105 cells/well, fixed in 4% paraformalde-
hyde for 30  min on ice, and then washed thrice on ice 
with DPBS. Cells were blocked with 3% BSA for 30 min, 
stained with or without mouse anti-DDR2 Ab (R&D Sys-
tems) at 4  °C overnight, and then incubated with Alexa 
Fluor 488-conjugated goat anti-mouse Ab (A32723, Inv-
itrogen) for 45 min in the dark. The nuclei were stained 
with 4′,6-diamidino-2-phenylindole (DAPI) and cells 
were observed with a FluoView FV1000 confocal micro-
scope (Olympus, Tokyo, Japan).
For C1q binding assay, HT1080 cells were cultured and 
incubated with 2 μg/mL C1q in a serum-free medium for 
2 h. sDDR2 (2 μg/mL) was also co-incubated to observe 
the inhibition of C1q and cell surface DDR2 bind-
ing. After treatment, the cells were washed, fixed, and 
blocked as described above. The cells were then stained 
with or without mouse anti-DDR2 Ab (R&D Systems) 
and with or without rabbit anti-C1q Ab (Dako) at 4  °C 
overnight. After they were washed thrice, the cells were 
incubated with Alexa Fluor 488-conjugated goat anti-
rabbit Ab (A11008, Invitrogen) for C1q or Alexa Fluor 
594-conjugated goat anti-mouse Ab for DDR2 (A32742, 
Invitrogen) for 45 min in the dark, and then mounted and 
examined using confocal microscopy. To determine the 
percentage colocalization of both proteins, images were 
loaded onto Image J software (NIH, Rockville, MD, USA) 
and the ratios of green or red to merged cells were meas-
ured using the colocalization plug-in.
Proximity ligation assay
Proximity ligation assay (PLA) was performed accord-
ing to the manufacturer’s protocol (Duolink®, Sigma-
Aldrich). Cells were washed with cold DPBS, fixed with 
4% paraformaldehyde for 30 min on ice, blocked with 3% 
BSA for 30 min, and then stained with or without mouse 
anti-DDR2 Ab (R&D Systems) and with or without rabbit 
anti-C1q Ab (Dako) at 4  °C overnight. The cells were 
incubated with the corresponding PLA probes conju-
gated to oligonucleotides (mouse MINUS and rabbit 
PLUS), followed by ligation and rolling circle amplifica-
tion in proximity. The nuclei were stained with DAPI, 
and cells were observed using FluoView FV1000 confocal 
microscope. Interactions were quantified by counting the 
number of dots per cell using Image J software.
Western blotting and immunoprecipitation
HT1080 cells were stimulated with 20  μg/mL of colla-
gen-I, C1q (A099, Complement Technologies, Tyler, TX, 
USA) or C1qA peptide (Biotin-GSKGEQGEPGAPGI, 
GenScript) for the indicated time points. Cells were lysed 
in RIPA cell lysis buffer containing protease and phos-
phatase inhibitors (GenDEPOT Inc., Katy, TX, USA) to 
obtain protein extracts. Protein concentration was deter-
mined using the BCA protein assay kit (Pierce Biotech, 
Rockford, IL, USA). The following primary antibodies 
were used: mouse anti-DDR2 (MAB2538; R&D Systems), 
rabbit anti-DDR2 (12133; Cell Signaling Technology, 
Danvers, MA, USA), rabbit anti-C1q (A0136; Dako), rab-
bit anti-pp38 (9211S; Cell Signaling Technology), rabbit 
anti-p38 (9212; Cell Signaling Technology), rabbit anti-
pERK1/2 (9101; Cell Signaling Technology), rabbit anti-
ERK1/2 (9102; Cell Signaling Technology), and rabbit 
anti-β-actin (4967; Cell Signaling Technology) Abs. For 
western blotting, equal amounts of protein or immuno-
precipitated proteins in protein sample buffer (100  mM 
Tris–HCl at pH 6.8, 2% SDS, 25% glycerol, 0.1% bromo-
phenol blue, and 5% β-mercaptoethanol) were resolved 
by 8 or 12% SDS-PAGE and transferred to nitrocellulose 
membranes (Amersham Biosciences, Buckinghamshire, 
UK). After blocking in tris-buffered saline containing 
5% skim milk and 0.1% Tween-20, the membranes were 
incubated with primary antibodies, followed by incuba-
tion with HRP-labeled secondary antibodies. West-Q 
Pico ECL solution (GenDEPOT Inc.) was used to develop 
the images.
To observe DDR2 phosphorylation, phosphotyrosine 
immunoblot was performed after DDR2 immunoprecipi-
tation using rabbit anti-DDR2 Ab (12133; Cell Signaling 
Technology) at 4  °C overnight. Pre-equilibrated Dyna-
beads-conjugated protein G (10003D; Invitrogen) was 
incubated with the Ab at 4 °C for 1 h. Samples were sub-
sequently immunoblotted by mouse anti-phosphotyros-
ine Ab (4G10; MP-05–321; Millipore, Burlington, MA, 
USA) after washing for western blotting.
In vitro cell wound healing assay
HT1080 cells were grown to confluence in 12-well plates 
(Corning) and a straight scratch was made in each well 
using a 1 mL-pipette tip. The cells were then washed with 
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DPBS twice and further cultured with collagen-I (20 μg/
mL) or C1q (20 μg/mL) for the indicated time. The gap 
of the scratch was recorded using an Olympus IX73 
inverted microscope (Olympus).
CytoSelectTM Wound Healing Assay Kit (HT1080 cells 
(Cell Biolabs, San Diego, CA, USA) was used (Fig. 5E and 
F). Briefly, HT1080 cells (3 ×  105 per well) were cultured 
in a 24-well plate until they form a monolayer around the 
insert that could generate a defined wound field or gap. 
Cells were treated with C1q (20  μg/mL; A099, Comple-
ment Technologies), C1qA peptide (200  nM) or sDDR2 
(2  μg/mL; R&D Systems) in serum free X-VIVO media 
(Lonza, GA, USA). The wound field surface area was vis-
ualized via phase contrast or DAPI fluorescence labeling. 
Images were taken in three different areas per well using 
an Evos M7000 microscope (Thermo Fisher Scientific) at 
the indicated time points. The wound closure area was 
determined at each time point from the digital images 
using Image J and the wound healing rate was calculated 
as the (covered wound area/total surface area) × 100.
Short hairpin RNA and transfection assay
DDR2 knockdown was achieved using stable short 
hairpin interfering RNAs (shRNAs). To target DDR2 
(NM_006182 NCBI), we used #TRCN0000001418 (Yon-
sei Genomics Center System Biology Core, Seoul, Korea). 
#SHC016 was also used as scramble sequence shRNA. 
HT1080 cells were transfected using Fugene HD trans-
fection reagent (Roche Diagnostics) according to the 
manufacturers’ instruction for 36 h. The knockdown effi-
ciency was determined by western blotting using rabbit 
anti-DDR2 Ab (12133; Cell Signaling Technology). DDR2 
knockdown HT1080 cells were subsequently plated on 
12-well plates 48 h after transfection and incubated over-
night. The wound healing assay was performed up to 72 h 
after transfection.
Gelatin zymography
HT1080 cells were treated with collagen-I or C1q (20 μg/
mL) in serum-free medium, then harvested, briefly cen-
trifuged, and immediately frozen at − 20  °C to prevent 
auto-activation of MMPs. Aliquots of medium were later 
prepared in native buffer. Proteins were resolved by 8% 
polyacrylamide gels containing 0.1% gelatin without boil-
ing. Gels were incubated in 1 × Zymogram Renatura-
tion Buffer (Bio-Rad, Hercules, CA, USA) for 30  min, 
washed with distilled water, and incubated in 1 × Zymo-
gram Development Buffer (Bio-Rad) for 30  min. Then, 
the gels were incubated in fresh 1 × Zymogram Devel-
opment Buffer overnight at 37  °C and later stained with 
0.5% Coomassie brilliant blue in 10% acetic acid and 50% 
methanol. The gels were destained with 50% methanol 
and 10% acetic acid and observed using a MiniBIS Pro 
imager (DNR Bio-Imaging Systems Ltd., Neve Yamin, 
Israel).
Dot blot assay
Recombinant proteins (20  μg per spot), such as NS0-
derived recombinant mouse DDR2-Fc chimera protein 
(7479-DR, R&D Systems), DDR1-Fc (6416-DR, R&D Sys-
tem) or Fc (4460-MG, R&D Systems) were blotted onto 
a nitrocellulose membrane. Both the DDR2 ectodomain 
(Gln24-Arg399) and DDR1 ectodomain (Met1-Thr414) 
fused with Mouse  IgG2A (Glu98-Lys330) at the C-termi-
nal. The membrane was dried and blocked with 5% skim 
milk in PBS at RT for 1  h. Biotinylated C1qA peptide 
(200 nM) in 3% skim milk were incubated at RT for 2 h. 
The blots were washed thrice in 0.05% PBST and incu-
bated with InfraRed 680 conjugated-streptavidin for 1 h. 
The signals were detected by the Sapphire™ Biomolecular 
Imager (Azure Biosystems, CA, USA).
Quantitative real time‑PCR
Total RNA was extracted from cells with an RNeasy 
kit (Qiagen), and cDNA was generated using an iScript 
cDNA synthesis kit (Bio-Rad). Real Time-PCR reactions 
were performed on a Light Cycler 480 II (Roche) using 
Light Cycler 480 Probes Master (Roche). Primers for 
MMP9 (Hs00957562) and HPRT1 (Hs02800695) were 
purchased from Thermo Fisher Scientific. The genes 
of interest were normalized to the housekeeping gene, 
HPRT1, and  2−ΔCt was used to calculate the relative 
expression. Relative fold increase was analyzed using the 
 2−ΔΔCt method compared to untreated control.
Statistical analysis
Results were presented as the mean ± standard error of 
the mean (SEM) mentioned in each figure legend. Data 
were analyzed using IBM SPSS Statistics version 22.0 
(IBM Corp., Armonk, NY, USA) and GraphPad Prism 9 
(GraphPad Software, San Diego, CA, USA). Comparisons 
between more than three groups were analyzed via one-
way ANOVA and the Student’s t test was used to com-




DDR2 binding to C1q was examined using ELISA. As 
binding of collagen-I with DDR2 is well known, we 
tested this binding as the experiment for positive con-
trol. Microtiter wells were coated with 2  μg/mL colla-
gen-I and BSA, and various concentrations of sDDR2 
protein were added. As expected, sDDR2 bound with 
collagen-I in a concentration-dependent manner, while 
it did not bind with BSA (Fig. 1A). Next, the binding of 
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sDDR2 with C1q was tested. sDDR2 protein was added 
to the microwells coated with C1q at 8  μg/mL. As 
shown in Fig. 1B, sDDR2 bound with C1q in a concen-
tration-dependent manner but did not bind with BSA. 
In the reverse experiment, C1q was added to microti-
ter plates coated with 2 μg/mL sDDR2. C1q bound with 
sDDR2 in a concentration-dependent manner but did 
not bind with BSA (Fig.  1C). Next, we performed an 
immunoprecipitation assay to confirm the interaction 
between C1q and DDR2. Equal concentrations (100 ng/
mL) of C1q and sDDR2 protein tagged with 6 × His 
were mixed and pull-down assay was conducted with 
His-tag-sensitive resin. C1q protein bound to sDDR2 
was observed using western blotting. Two clear C1q 
bands (29 and 27 kDa) were observed when both pro-
teins were present (Fig.  1D). Moreover, SPR showed 
the interaction of C1q with sDDR2 immobilized on the 
CM5 chip in a concentration-dependent manner.  KD 
Fig. 1 C1q binds to DDR2. A, B Microtiter plates were immobilized with 2 μg/mL collagen‑I (A) and 8 μg/mL C1q (B). Respective concentrations of 
BSA were also coated as a negative control protein. Various concentrations of sDDR2 were added to the wells and ELISA was conducted to observe 
the binding. Blank well values were subtracted for analysis. C Microtiter plates were immobilized with 2 μg/mL each of sDDR2 and BSA, and various 
concentrations of C1q (0.1, 0.5, 2, and 8 μg/mL) were added to evaluate the binding of DDR2 with C1q. The graph shows the mean ± SEM of three 
independent experiments. *** p < 0.001 (one‑way ANOVA). D Pull‑down assay of 100 ng sDDR2 and 100 ng C1q were tested with Sepharose‑based 
complete His‑tag purification resin. Antibodies for western blot analyses are as indicated. E Surface plasmon analysis of C1q binding to DDR2. 
Various concentrations of C1q protein (0, 2.5, 5, 10, 20, and 40 μg/mL) were applied on an sDDR2‑immobilized sensor chip CM5
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value is 1.83 ×  10–7  M, indicating that C1q has a high 
binding affinity for sDDR2 (Fig. 1E).
C1q binds to DDR2 expressed by HT1080 cells
We observed DDR2 expression in the HT1080 epithe-
lial cell line via confocal microscopy and flow cytom-
etry (Fig.  2A). Next, we tested whether C1q binds to 
DDR2-expressing HT1080 cells by adding 2 μg/mL C1q 
protein to the cultures for 2  h. Then, C1q (green) and 
DDR2 (red) were detected using specific antibodies and 
the merged images were observed via confocal micros-
copy. C1q and DDR2 were colocalized on the HT1080 
cell surface (Fig.  2B). The specificities of these inter-
actions were further demonstrated through blocking 
experiments. The colocalization of C1q and DDR2 was 
reduced in the presence of 2 μg/mL sDDR2, confirming 
that C1q can bind with DDR2 (Fig. 2B). Similar results 
were observed in the PLA. Polymerase-amplified fluo-
rescence showed C1q-DDR2 colocalization, and the 
addition of sDDR2 inhibited the C1q-DDR2 proximity 
(Fig. 2C).
C1q promotes wound healing by binding with DDR2
To determine whether C1q mediates DDR2 phos-
phorylation, HT1080 cells were stimulated with sev-
eral concentrations of C1q and collagen-I for 24  h. 
Then, DDR2 phosphorylation was determined via 
immunoprecipitation with anti-DDR2 Ab followed 
by immunoblot analysis for phosphotyrosine. While 
collagen-I phosphorylated DDR2 in a dose-dependent 
manner, 20  μg/mL of C1q drastically increased DDR2 
phosphorylation in HT1080 cells at 24 h (Fig. 3A).
Confluent monolayers of HT1080 cells were wounded 
with a uniform scratch and washed to remove debris. 
The cells were incubated in the absence or presence of 
C1q for a specific duration and the wound healing rate 
was measured accordingly. Wound closure increased 
significantly with 20  μg/mL C1q treatment in a time-
dependent manner (Fig. 3B).
To determine the significant role of DDR2 in C1q 
wound healing, DDR2 was transiently knocked down 
using shRNAs in the HT1080 cell line. DDR2 expres-
sion was ~ 70% downregulated by shRNA transfection 
at 36 h after transfection (Fig. 3C). Subsequently, DDR2 
shRNA or scrambled control RNA-transfected HT1080 
cells were further assessed using an in  vitro scratch 
test for up to 72 h after transfection. C1q-induced cell 
migration decreased in DDR2 shRNA-transfected cells 
by ~ 23% compared to control cells (Fig. 3D). These data 
suggest that C1q-DDR2 binding induces cell migration.
C1q induces MMP2 and MMP9 expression via p38 
and ERK1/2 pathways
MMP2 and MMP9 productions were tested by C1q 
stimulation at 20  μg/mL in HT1080 cells. Gelatin 
zymography showed that active MMP2 and MMP9 
expression were significantly induced by C1q treatment 
similar to collagen-I treatment in a time-dependent 
manner (Fig. 4A–C). Furthermore, we investigated the 
phosphorylation status of p38 and ERK1/2 in HT1080 
cells at different time points following treatment with 
20 μg/mL collagen-I and C1q to assess the related sign-
aling pathways (Fig. 4D–F). C1q significantly increased 
p38 and ERK1/2 phosphorylation in a time-depend-
ent manner for 24 h after treatment. Moreover, DDR2 
phosphorylation was also continuously increased for 
24  h, demonstrating that C1q is a novel functional 
ligand of DDR2 (Fig. 4D).
The C1q collagen region is the DDR2 binding site
To confirm that the C1q collagen structure is a criti-
cal region for DDR2 binding, we tested whether DDR2 
binds with a synthetic C1q collagen tail peptide (C1qA 
peptide) that is known to bind with LAIR-1 (Liu et al. 
2019). We found that it binds both DDR2 and DDR1 
(Fig.  5A). C1qA bound to sDDR2 in a concentration-
dependent manner according to the results of ELISA 
(Fig.  5B and C) and pull-down assay (Fig.  5D). Fur-
thermore, C1qA peptide promotes wound healing 
(Fig.  5E). The enhanced wound healing effect of C1q 
and C1qA peptide was diminished by sDDR2 (Fig. 5F). 
To observe the direct effect of C1qA peptide on DDR2 
activation, we tested whether C1qA peptide can cause 
the autophosphorylation of DDR2. C1qA peptide 
induced DDR2 phosphorylation after 24  h of stimula-
tion (Fig. 5G) and enhanced the expression of MMP-9 
(Fig. 5H).
Discussion
A complete understanding of the phases of the heal-
ing process is essential for recognizing factors that may 
complicate or delay wound healing (Thomas 2011). 
ECM remodeling is important in re-epithelialization 
and is associated with MMP production. Fibroblasts 
in acute human wounds express MMP2, and MMP9 
is expressed in several injured epithelia to promote 
wound healing (Marquez and Olaso 2014). Stud-
ies have indicated the correlation between p38 kinase 
and ERK1/2 pathways with MMP2 and MMP9 activity 
(Yu and Kim 2016; Gweon and Kim 2013). This study 
shows for the first time that DDR2 is the receptor 
for C1q that is involved in wound healing and is pre-
sent on the surface of epithelial cells. C1q and DDR2 
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Fig. 2 Co‑localization of C1q to DDR2‑expressing cells. A DDR2 expression in the HT1080 cell line was determined using confocal microscopic 
images and flow cytometric analyses. B Confocal microscopy analysis showing co‑localization of C1q with DDR2 in HT1080 cells. The cells were 
treated with 2 μg/mL C1q in the absence or presence of 2 μg/mL sDDR2. Confocal images of the cells show dual staining for DDR2 (red) and C1q 
(green). The phenomenon was attenuated with the addition of sDDR2. C Proximity ligation assay (PLA) of DDR2 and C1q. The graph shows the 
mean ± SEM of three independent experiments. *** p < 0.001, **** p < 0.0001 (one‑way ANOVA)
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binding improved cell migration and induced MMP2 
and MMP9 expression in HT1080 epithelial cells.
Our previous data showed that C1q binds to DDR1 
and promotes hepatocellular tumor progression (Lee 
et  al. 2018). Although both DDRs are similar, they have 
distinct functions, expression profiles, and sequential 
roles in inflammation response, depending on the micro-
environment and cell types (Afonso et  al. 2013). DDR1 
expression is increased in the glomeruli of patients with 
lupus nephritis (Kerroch et  al. 2012). DDR2 expression 
increases in the cartilage of patients with osteoarthri-
tis and correlates with the degree of cartilage damage in 
human knee joints (Sunk et  al. 2007). Therefore, their 
functional differences might be related to their expres-
sion profiles and location (Abbonante et al. 2013). More-
over, other collagen-like structures containing molecules 
Fig. 3 C1q‑DDR2 binding promotes wound healing. A DDR2 phosphorylation was evaluated by immunoprecipitation with rabbit anti‑DDR2 Ab 
and western blot with anti‑phosphotyrosine Ab (4G10) or mouse anti‑DDR2 Abs. HT1080 cells were incubated with the indicated concentration 
of collagen‑I or C1q for 24 h. One representative image of three independent experiments. B HT1080 cells were grown to confluence in 12‑well 
plates; a straight scratch was made and then treated with 20 μg/mL C1q for the indicated time. The wound areas were calculated and expressed 
as the percentage of wound closure to the initial wound areas. Values are presented as the means ± SEM of three independent experiments. C 
Western blot of DDR2 knockdown in HT1080 cells. D The wound healing assay was performed as described in 3B after transfection of DDR2 shRNA 
or scrambled control RNA (shSCR). Values are presented as the means ± SEM of three independent experiments. * p < 0.05, ** p < 0.01, *** p < 0.001 
(one‑way ANOVA)
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such as surfactant proteins or adiponectin may also be 
potential DDR ligands (Haczku 2008; Sun et al. 2016).
While C1q regulates non-hematopoietic cells such as 
epithelial cells, C1q also involves macrophage differen-
tiation (Son et al. 2016; Bohlson et al. 2014). Thus, C1q 
may modulate infiltrated hematopoietic cells by engaging 
its receptors in a time-dependent manner in the wound 
tissue. Since C1q activates phosphoinositide 3 kinase/
Akt signaling directly to DDR1 (Lee et  al. 2018), PI3K/
AKT might be upstream of ERK1/2 and p38. The level 
of C1q is increased with age and delays wound healing 
by modulating Wnt signaling (Naito et al. 2012). During 
Fig. 4 C1q induces MMP2 and MMP9 expression via p38 and ERK phosphorylation. A–C Effects of C1q on MMP2 and MMP9 production in HT1080 
cells were detected via a gelatin zymography assay. The relative amounts of MMP2 (B) and MMP9 (C) were quantified using Image J. Collagen‑I 
was used as a positive control. SE: short exposure, LE: long exposure. D–F HT1080 cells were treated with or without 20 μg/mL collagen‑I and C1q 
for the various time points indicated. The expression of p‑p38, p38, p‑ERK1/2, ERK1/2, and ß‑actin were detected using western blotting. DDR2 
phosphorylation was tested after the immunoprecipitation of DDR2. The fold induction compared to untreated samples (NT, 0 h) was quantified 
using Image J. Data are presented as the means ± SEM of three independent experiments. * p < 0.05, ** p < 0.01, *** p < 0.001 (one‑way ANOVA)
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acute wound healing, pro-inflammatory macrophages 
infiltrate the wound site after injury to clean the wound 
of microorganisms and apoptotic debris. As the tissue 
resolves inflammation, the overall macrophage popu-
lation transitions to anti-inflammatory macrophages 
(Aonuma et al. 2021). Additionally, C1q could bind with 
the DAMP molecule HMGB1, which is secreted under 
proinflammatory oxidative conditions. Further study is 
necessary to clarify the effect of wound healing process of 
both molecules interacting with DDR2 (Kim et al. 2018; 
Kwak 2019). Thus, C1q may perform multiple functions 
in complicated wound regions by engaging its receptors.
Fig. 5 DDR2 as a receptor for cC1q in HT1080 epithelial cells. A C1q collagen tail peptide (C1qA peptide) binds with DDR2. Recombinant mouse 
DDR2‑Fc chimera protein (7479‑DR), DDR1‑Fc (6416‑DR), or control Fc (4460‑MG) (20 μg per spot) were blotted onto the nitrocellulose membrane, 
and then detected using biotinylated C1qA peptide (200 nM). Representative image of three independent experiments. B, C Microtiter plates were 
immobilized with C1qA peptide or control peptide (8 μg/mL, B), sDDR2 (2538‑DR), or BSA (8 μg/mL, C). sDDR2 (2538‑DR; 0, 0.1, 0.5, 2.0 and 8 μg/
mL, B) or C1qA peptide (0, 0.1, 0.5, 2.0 and 8 μg/mL, C) were added to the plates. Plate‑bound peptides were detected using anti‑His antibody (B) or 
AP‑conjugated streptavidin (C). The graph shows the mean ± SE of three independent experiments. ***p < 0.001. D Pull‑down assay of 0, 1, and 5 μg 
sDDR2 and 10 μg C1qA peptide‑coupled streptavidin beads. C1qA peptide‑bound sDDR2 was detected by anti‑DDR2 Ab (MAB25381). The input 
of C1qA peptide was visualized by dot blot using infrared 800‑labeled streptavidin. E Wound healing effects of C1q and C1qA peptide. HT1080 cells 
were treated with or without 20 μg/mL C1q or 200 nM C1qA peptide for the indicated duration. The percentage of wound closure to the initial 
wound areas were calculated using Image J. The graph shows the mean ± SEM of four independent experiments. F sDDR2 inhibits the wound 
healing effect of C1q and C1qA peptides. sDDR2 (2 μg/mL) was co‑incubated with C1q or C1qA peptide for 2 h, and the wound healing rate was 
determined as described in E. Data represent the mean ± SEM of four independent experiments. * p < 0.05, ** p < 0.01, *** p < 0.001, ****p < 0.0001 
(one‑way ANOVA). G C1qA peptide induces DDR2‑autophosphorylation. HT1080 cells were treated with 20 μg/mL of collagen‑I or C1q or C1qA 
peptide for 24 h. DDR2 phosphorylation was determined by immunoprecipitation with anti‑DDR2 Ab and western blot with anti‑phosphotyrosine 
(4G10) Ab. The bar graph shows the mean ± SEM of three independent experiments. * p < 0.05 (one‑way ANOVA). H MMP‑9 mRNA expression in 
HT1080 cells treated as described in 5G. Data represent the mean ± SEM of three independent experiments. ** p < 0.01 (one‑way ANOVA)
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Collagen peptides and LAIR-1 ligand peptides have 
been developed to promote cell-specific receptor func-
tions (Liu et al. 2019; Son and Diamond 2015). Accord-
ing to this study, the impact of the C1qA peptide may 
not be limited to LAIR-1 on hematopoietic cells. DDR2 
is well known to bind to the triple-helical form of colla-
gen, and not to denatured collagen or collagen-mimetic 
peptides that are not triple-helical form (Carafoli et  al. 
2009; Konitsiotis et  al. 2008). Further investigation is 
necessary how C1qA peptide, which does not appear to 
be triple-helical, bind DDR2. Our findings are poten-
tially applicable in repurposing opportunities for treating 
inflammation and promoting wound healing. The present 
in vitro study would be helpful in preclinical models for 
wound healing studies (Caetano et al. 2015; Pegorin et al. 
2021). Further understanding of physiological C1q bind-
ing to DDR2 is necessary for therapeutic applications in 
wound healing-related diseases.
Conclusion
This work uncovers the interaction of C1q and DDR2, 
which promotes wound healing and possibly angiogen-
esis. C1q and DDR2 binding improved cell migration 
and induced MMP2 and MMP9 expression involved in 
wound healing in vitro.
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